RDEA 806
RDEA 806 is an orally effective non-nucleoside reverse transcriptase (NNRT) inhibitor that exhibits potent in vitro inhibitory activity against wild-type HIV-1 (EC50 = 1.7 ng/mL) and NNRTI-resistant HIV-1. RDEA 806 is a prodrug of Lesinurad (HY-15258) and functions as a URAT1 inhibitor, exerting a uric acid-lowering effect. RDEA 806 rapidly reduces HIV-1 RNA viral load in vivo. RDEA 806 has a favorable biosafety profile. RDEA 806 can be used for research related to HIV-1 infection.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 878670-61-2
- 分子式: C24H18BrClN4O3S
- 分子量:557.85
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
体外実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
化学情報
-
CAS 番号 878670-61-2
-
分子量 557.85
-
分子式 C24H18BrClN4O3S
-
SMILES
ClC(C=C(C(O)=O)C=C1)=C1NC(CSC2=NN=C(Br)N2C3=CC=C(C4CC4)C5=C3C=CC=C5)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Moyle G, et al. Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects. Antimicrobial agents and chemotherapy. 2010 Aug;54(8):3170-8. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
RDEA 806 関連分類
HY-105249 関連分類
Powered by Bioz
Keywords
- RDEA 806
- 878670-61-2
- RDEA806
- RDEA-806
- HIV
- Reverse Transcriptase
- URAT1
- Human immunodeficiency virus
- Urate transporter 1
- SLC22A12
- HIV-1 RNA viral load
- HIV-1-infected subjects
- HIV-1 infection
- oral agent
- NNRTI-resistant mutants
- NNRTI-resistant
- NNRTI
- wild-type
- antiretroviral-na?ve
- HIV-1 reverse transcriptase
- Inhibitor
- inhibitor
- inhibit